Brown Advisory Inc Cerus Corp Transaction History

Brown Advisory Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$4.89 - $7.16 $64,298 - $94,146	-13,149 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$6.89 - $7.78 $28,979 - $32,722	-4,206 Reduced 24.24%	13,149 $95,000
Q2 2018 Aug 10, 2018	BUY	$5.19 - $7.25 $27,948 - $39,041	5,385 Added 44.99%	17,355 $116,000
Q1 2018 Jun 28, 2018	BUY	$3.56 - $5.74 $42,613 - $68,707	11,970 New	11,970 $65,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.